Stemline Therapeutics Inc. (STML) Slipped -6.23% or -1.0 To Price $15.05 On Friday


Stemline Therapeutics Inc. (STML) slipped -6.23% or -1.0 to $15.05. It is around 253563 shares traded, which is 149.15% compare to the average total volume 170006. The market cap of STML is $466.17 million. The year to date change is -3.68%. The 52 week price range is from $10.2 to $20.55. Price of STML have changed -6.25% during last week. It have changed -0.62% over last month, -3.89% over last 3 months, -9.58% over last 6 months and 31.56% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for STML is 16.11. It is 7.04% above current price. The 200-day Moving Averages for STML is 16.49. It is 9.57% above current price. The 52-week High is 20.55. It is 36.54% from the current price. The 52-week Low is 10.2. It is -32.23% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of STML is 10.04 on 2018-09-28. Short % to float is 5.35%. There are some statistics of STML. It is has market cap $466.17 million. The share outstanding is 30.98 million. The average volume is 170006. The revenue is 299397. The percent of top 15 Institution holding is 65.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of STML is -93.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of STML is -77.60%.


Tags:

Share this post